Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.

This study has been completed.
Information provided by:
Scios, Inc. Identifier:
First received: December 22, 2005
Last updated: June 9, 2011
Last verified: June 2011